{
  "report_rows": [
    {
      "kpi": "Q2 2026 revenue",
      "prediction": "BEAT",
      "answer": "pred ~$1.55B vs. cons $1.53B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 non-GAAP diluted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$4.56 vs. cons $4.44",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 adjusted EBITDA margin",
      "prediction": "BEAT",
      "answer": "pred ~21.5% vs. cons 21.2%",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 sales growth",
      "prediction": "BETTER",
      "answer": "guide ~12.5% vs. cons 12.3% (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 non-GAAP diluted EPS",
      "prediction": "BETTER",
      "answer": "guide ~$18.90 vs. cons $18.75 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 adjusted EBITDA margin",
      "prediction": "UNCHANGED",
      "answer": "guide ~22.0% vs. cons 22.0% (FY2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 4.3,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 2.6,
  "day5_path": "FADE",
  "day5_rationale": "Predicted Q2 EPS of ~$4.56 vs. $4.44 consensus supports an initial gain, but FY2026 guidance of ~$18.90 vs. $18.75 consensus implies H2 EPS of approximately $9.59 vs. $9.56 consensus. Near-flat out-period revisions and the strong pre-earnings rally should fade part of the day-1 move.",
  "day5_confidence": "MEDIUM"
}